Hematology/Oncology

Top Story

Diverse gut microbiome may improve response to immunotherapy for melanoma

Diverse gut microbiome may improve response to immunotherapy for melanoma
February 21, 2017

Patients with melanoma who responded to immunotherapy had a more diverse gut microbiome than nonresponders, according to study results scheduled for presentation at the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium.

These results suggest that modifications to the gut microbiome could potentially improve a patient’s response to anti–PD-1 therapy.

In the Journals

Physical activity reduces risk for breast cancer recurrence

February 21, 2017
Exercising is the most important lifestyle change a woman can make to prevent breast cancer recurrence and mortality, according to a systematic review recently published…
FDA News

FDA grants priority review to inotuzumab ozogamicin for ALL

February 21, 2017
The FDA granted priority review to inotuzumab ozogamicin for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, according…
In the Journals PlusPerspective

Alternating treatment fails to delay progression of advanced renal cell carcinoma

February 21, 2017
An 8-week treatment rotation of pazopanib and everolimus failed to improve survival or quality of life in patients with advanced renal cell carcinoma, according to…
Curbside Consultation

Managing Hypoechoic Pancreatic Lesions: Follow-up EUS vs. FNA

Healio Gastroenterology, February 2017
Jason B. Samarasena, MD; Kenneth J. Chang, MD, FACG, FASGE
A: First, it is important to describe what a vague hypoechoic lesion of the pancreas means to an endosonographer (Figure 1). Any lesion that is large, well…
More News Headlines »
CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »
Video
Meeting News Coverage

VIDEO: Extended adjuvant endocrine therapy may be effective in select patients

January 5, 2017
More »
Featured
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement